Insmed, Inc.
Edit Page
Report
Scan day: 12 February 2014 UTC
8
Virus safety - good
Description: Protein manufacturing facility concentrated on developing treatments for metabolic and endocrine disorders. Details of investor relations and cGMP process manufacturing at Boulder, Colorado. (Nasdaq: INSM)
ARIKACE for CF Patients with Pseudomonas Lung Infections ARIKACE for Patients with NTM Lung Infections ARIKACE for Non-CF Bronchiectasis Patients with Pseudomonas Lung Infections Proprietary Liposomal Technology
Size: 211 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Insmed |
| Keywords: | |
| Description: | Insmed's mission is to improve the treatment of serious orphan diseases through the development of novel, site-specific, inhaled liposomal drug products and to efficiently and effectively move our product candidates through the regulatory approval process. |
| IP-address: | 208.74.85.2 |
WHOIS Info
| NS | Name Server: NS.GWSINC.COM Name Server: NS2.GWSINC.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 06-jun-1996 Expiration Date: 05-jun-2015 |